Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Arthritis, Rheumatoid 8Melanoma 6Colitis, Ulcerative 6Inflammatory Bowel Diseases 5Crohn Disease 5Carcinoma, Non-Small-Cell Lung 4Lung Neoplasms 3Colitis 3Urogenital Neoplasms 2Inflammation 2Hematologic Neoplasms 2Graft vs Host Disease 2Fatigue 2Depressive Disorder, Major 2Depression 2Cachexia 2Anorexia 2Vasculitis 1Takayasu Arteritis 1Syndrome 1Stroke 1Stevens-Johnson Syndrome 1Spondylitis, Ankylosing 1Skin Neoplasms 1Recurrence 1Rare Diseases 1Psoriasis 1Precancerous Conditions 1Pemphigoid, Benign Mucous Membrane 1Pancreatic Neoplasms 1

Interventions

Exercise 5Vitamin D 3Resistance Training 3Omeprazole 3Etanercept 3Dexmedetomidine 3Ascorbic Acid 3salicylsalicylic acid 2palbociclib 2epigallocatechin gallate 2XENP 1595 2Tea 2Tablets 2Surgical Procedures, Operative 2Sufentanil 2Spironolactone 2Probiotics 2Pioglitazone 2Oxycodone 2Nutrition Assessment 2Morphine 2Metformin 2Ketorolac 2Infliximab 2Ibuprofen 2Fish Oils 2Endurance Training 2Colchicine 2Blood Specimen Collection 2Aspirin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Inflammation × Infliximab × Clear all
NCT06136546 2025-05-07

Cognitive Dysfunction and Inflammation in Depression: Experimental Inhibition Via Infliximab

Massachusetts General Hospital

Phase 2 Recruiting
100 enrolled

Depression, Depressive Disorder, Major, Inflammation, Cognitive Dysfunction

NCT02743390 2017-11-09

Effects of the TNF-alpha Inhibiton on Hemodynamic Parameters in Resistant Hypertension

University of Campinas, Brazil

Phase 4 Completed
10 enrolled

Hypertension, Inflammation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡